Loxcell Junior Suspension 400mg/200mg 20ml (Albendazole/Quinfamide)

Category

Antiparasitics

Line

Loxcell

Brand

Dinafarma

Molecule

Albendazole/Quinfamide

Presentation

Suspension 400Mg/200Mg 20Ml

Laboratory

Dinafarma

Indications

Loxcell Junior is indicated for the treatment of intestinal infections caused by helminths, such as ascariasis, enterobiasis, and other parasitic infections. This medication combines the action of two molecules, Albendazole and Quinfamide, which act synergistically to eliminate intestinal parasites in children. Its use is recommended in pediatric patients for the control and treatment of infections caused by Giardia lamblia and other susceptible organisms. The efficacy of the product has been proven in clinical studies that demonstrate its ability to eradicate common parasitic infections in the pediatric population.

Composition

Each 10 ml of Loxcell Junior Suspension contains: 400 mg of Albendazole and 200 mg of Quinfamide, as well as necessary excipients for the product's formulation.

Contraindications

This medication is contraindicated in patients who are hypersensitive to any of the components of the formula. Its use is not recommended in patients with severe liver disease or in pregnant women, unless indicated by a physician. It should be avoided in patients with a history of adverse reactions to similar treatments.

Precautions

It is important to maintain medical follow-up during treatment, especially in patients with liver or kidney diseases, as well as in those who experience adverse drug reactions. Special care should be taken when administering to children under two years of age. An accurate diagnosis is recommended before starting treatment to ensure the correct indication of Loxcell Junior.

Storage

Store in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children and do not use after the expiration date indicated on the package.

Consult your doctor.